Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma

Completed

• Conditions: Carcinoma, Renal Cell
• Interventions: Other: We do not have any interventions. This study is based on obseravation.

• Registration Number: NCT06111560
• Lead Sponsor: Sun Yat-sen University

Brief Summary

Patients with renal cell carcinoma who were admitted to the First Affiliated Hospital of Sun Yat-sen University from February 1, 2021, to February 1, 2022, and met the following inclusion and exclusion criteria were collected. Clinical factors influencing the prognosis of enrolled patients were retrospectively analyzed, and a predictive system was established based on this.

(Inclusion criteria: pathology of the surgical specimen confirmed the diagnosis of pRCC,b: age 18 years or older, c: localized RCC underwent radical nephrectomy or partial nephrectomy in our center.

Exclusion criteria:a: lack of original CT images, b: patients with malignant tumors of other systems, c: patients who lost follow-up.)

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02-01
• Primary Completion: 2022-02-01
• Study Completion: 2022-02-01
• Status Verified: 2023-10
• Study First Submitted: 2023-10-27
• Study First Submitted QC: 2023-10-27
• Last Update Submitted: 2023-10-27
• Study First Posted: 2023-11-01
• Last Update Posted: 2023-11-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

a: pathology of the surgical specimen confirmed the diagnosis of pRCC,b: age 18 years or older, c: localized RCC underwent radical nephrectomy or partial nephrectomy in our center

Exclusion Criteria

a: lack of original CT images, b: patients with malignant tumors of other systems, c: patients who lost follow-up

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients without tumor progression or recurrence	We do not have any interventions. This study is based on obseravation.	Patients enrolled in our retrospective study without tumor progression or recurrence
Patients with tumor progression or recurrence	We do not have any interventions. This study is based on obseravation.	Patients enrolled in our retrospective study with tumor progression or recurrence

Primary Outcome Measures

Name	Time	Method
Tumor progression	12 months	medical imaging examinations showed tumor progression